Seed · Biotech · Cambridge, United Kingdom · Founded 2021 · 11–50 employees
ExpressionEdits is a biotechnology company optimizing protein expression using artificial intelligence and proprietary intronization technology through its Genetic Syntax Engine. By strategically incorporating multiple short, noncoding DNA sequences into artificial genes, the company significantly improves transgene expression, RNA processing, and overall protein yields. This technology helps unlock the production of previously difficult-to-manufacture therapeutic proteins for biologics and gene therapies. The Cambridge-based startup secured 13 million dollars in a Seed funding round in May 2024 to advance its proprietary platforms. Originally a spin-out from the University of Cambridge, the company recently moved to larger laboratory facilities at the Babraham Research Campus.
No open roles listed right now.